Tailoring the Composition of HA/PEG Mixed Nano-Assemblies for Anticancer Drug Delivery
Molecules · 2025
DOI: 10.3390/molecules30061349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Beatrice Zurletti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Science and Technology, University of Turin, Via Pietro Giuria 9, 10125 Turin, Italy. Hauptthemen laut MEDLINE: Polyethylene Glycols, Hyaluronic Acid, Antineoplastic Agents, Drug Carriers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Unione europea- Next Generation EU.
Abstract (Originalsprache)
Self-assembling amphiphilic polymers represent highly promising materials with emerging applications across various fields. In these polymers, the presence of hydrophilic and hydrophobic segments within their structure drives the self-assembly process in aqueous environments, leading to organized structures capable of incorporating lipophilic drugs. Their high chemical versatility enables the design of tailored structures to meet specific requirements, such as the active targeting ability, thereby broadening their potential applications. In this work, a polyethylene glycol-phospholipid conjugate was employed to form nanocarriers loaded with a lipophilic derivative of gemcitabine. To achieve nano-assemblies actively targeted towards cancer cells overexpressing the hyaluronic acid (HA) receptor CD44, a HA-phospholipid conjugate was co-formulated in various molar ratios (1%, 10%, and 20%). All formulations exhibited a mean diameter below 130 nm, a negative zeta potential (approximately −30 mV), and a high encapsulation efficiency (above 90%). These nano-assemblies demonstrated stability during storage and effectively released the encapsulated drug in a cell culture medium. Upon incubation with cancer cells, the nano-assemblies were internalized via a CD44 endocytosis-mediated mechanism, with the extent of internalization depending on the HA conjugate content. Consistently, cell viability studies revealed that the nanocarriers decorated with higher amounts of HA exerted a higher cytotoxicity, enabling a fine tuning of the nano-assembly properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Science and Technology, University of Turin, Via Pietro Giuria 9, 10125 Turin, Italy.
- Department of Oncology, Interdepartmental Center of Molecular Biotechnology "Guido Tarone", University of Turin, Via Nizza 44, 10126 Turin, Italy.
ORCID-Profile: Ilaria Andreana, Iris Chiara Salaroglio, Valeria Bincoletto, Maela Manzoli, Barbara Rolando, Paola Milla, Chiara Riganti, Barbara Stella
Förderung
- Italian Ministry of Health
- Unione europea- Next Generation EU
Zitieren
APA
Zurletti, B., Andreana, I., Salaroglio, I. C., Bincoletto, V., Manzoli, M., Rolando, B., Milla, P., Riganti, C., Stella, B., & Arpicco, S. (2025). Tailoring the Composition of HA/PEG Mixed Nano-Assemblies for Anticancer Drug Delivery. Molecules. https://doi.org/10.3390/molecules30061349
Vancouver
Zurletti B, Andreana I, Salaroglio IC, Bincoletto V, Manzoli M, Rolando B, et al. Tailoring the Composition of HA/PEG Mixed Nano-Assemblies for Anticancer Drug Delivery. Molecules. 2025. doi:10.3390/molecules30061349
BibTeX
@article{Zurletti2025,
author = {Zurletti, Beatrice and Andreana, Ilaria and Salaroglio, Iris Chiara and Bincoletto, Valeria and Manzoli, Maela and Rolando, Barbara and Milla, Paola and Riganti, Chiara and Stella, Barbara and Arpicco, Silvia},
title = {Tailoring the Composition of HA/PEG Mixed Nano-Assemblies for Anticancer Drug Delivery},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30061349}
}
EUVIMED